» Articles » PMID: 38374076

Substrate Promiscuity of Inositol 1,4,5-trisphosphate Kinase Driven by Structurally-modified Ligands and Active Site Plasticity

Overview
Journal Nat Commun
Specialty Biology
Date 2024 Feb 19
PMID 38374076
Authors
Affiliations
Soon will be listed here.
Abstract

D-myo-inositol 1,4,5-trisphosphate (InsP) is a fundamental second messenger in cellular Ca mobilization. InsP 3-kinase, a highly specific enzyme binding InsP in just one mode, phosphorylates InsP specifically at its secondary 3-hydroxyl group to generate a tetrakisphosphate. Using a chemical biology approach with both synthetised and established ligands, combining synthesis, crystallography, computational docking, HPLC and fluorescence polarization binding assays using fluorescently-tagged InsP, we have surveyed the limits of InsP 3-kinase ligand specificity and uncovered surprisingly unforeseen biosynthetic capacity. Structurally-modified ligands exploit active site plasticity generating a helix-tilt. These facilitated uncovering of unexpected substrates phosphorylated at a surrogate extended primary hydroxyl at the inositol pseudo 3-position, applicable even to carbohydrate-based substrates. Crystallization experiments designed to allow reactions to proceed in situ facilitated unequivocal characterization of the atypical tetrakisphosphate products. In summary, we define features of InsP 3-kinase plasticity and substrate tolerance that may be more widely exploitable.

Citing Articles

Research advances in huntingtin-associated protein 1 and its application prospects in diseases.

Wu Y, Wang Y, Lu Y, Yan J, Zhao H, Yang R Front Neurosci. 2024; 18:1402996.

PMID: 38975245 PMC: 11224548. DOI: 10.3389/fnins.2024.1402996.


Arg1 from lacks PI3 kinase activity and conveys virulence roles via its IP kinase activity.

Desmarini D, Liu G, Jessen H, Bowring B, Connolly A, Crossett B mBio. 2024; 15(6):e0060824.

PMID: 38742909 PMC: 11237472. DOI: 10.1128/mbio.00608-24.

References
1.
Mildvan A . Mechanisms of signaling and related enzymes. Proteins. 1997; 29(4):401-16. View

2.
Wang H, Falck J, Hall T, Shears S . Structural basis for an inositol pyrophosphate kinase surmounting phosphate crowding. Nat Chem Biol. 2011; 8(1):111-6. PMC: 3923263. DOI: 10.1038/nchembio.733. View

3.
Riley A, Jenkins D, Marwood R, Potter B . Synthesis of glucopyranoside-based ligands for D-myo-inositol 1,4,5-trisphosphate receptors. Carbohydr Res. 2002; 337(12):1067-82. DOI: 10.1016/s0008-6215(02)00103-9. View

4.
Liu C, Potter B . Synthesis of 3-Position-Modified Analogues of myo-Inositol 1,4,5-Trisphosphate, Tools for Investigation of the Polyphosphoinositide Pathway of Cellular Signaling. J Org Chem. 2001; 62(24):8335-40. DOI: 10.1021/jo970926y. View

5.
Miller G, Wilson M, Majerus P, Hurley J . Specificity determinants in inositol polyphosphate synthesis: crystal structure of inositol 1,3,4-trisphosphate 5/6-kinase. Mol Cell. 2005; 18(2):201-12. DOI: 10.1016/j.molcel.2005.03.016. View